ClinicalTrials.Veeva

Menu

Targeting Microbiota in Female Overactive Bladder Syndrome

Medical University of Vienna logo

Medical University of Vienna

Status

Enrolling

Conditions

Urinary Bladder, Overactive
Microbiota

Study type

Observational

Funder types

Other

Identifiers

NCT05328011
2160/2019

Details and patient eligibility

About

The aim of this study is to compare the urinary viral microbiome and bacterial microbiome between overactive bladder syndrome (OAB) patients and healthy controls in order to determine a possible alteration in the urinary microbiome which may predispose women for OAB, and also in order to determine a possible influence of the urinary viral microbiome on the urinary bacterial microbiome which may predispose the individual to OAB. Furthermore, we aim to compare the urinary bacterial microbiome to the vaginal, rectal, urethral and salivary bacterial microbiome within the same individual and between the two groups in order to determine a possible route of colonization of the urinary bladder.

Enrollment

100 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (case group):

  • symptoms of overactive bladder (urgency with or without urinary leakage, usually with frequency and nocturia)

Exclusion Criteria (case group):

  • Pregnant or lactating females

    • Neurological conditions (such as MS, Parkinson, spinal cord injury, stroke..)
    • Pelvic Organ Prolapse (stage ≥ 3)
    • Lower Urinary Tract surgery within past 6 months
    • Known history of interstitial cystitis or pain associated with OAB
    • Recurrent urinary tract infections > 3/year
    • Acute urinary tract infection
    • Urinary retention (with or without required self- catheterization)
    • Stress urinary incontinence or mixed urinary incontinence
    • Bladder cancer
    • Renal insufficiency
    • Urinary tract stones

Inclusion Criteria (control group):

without symptoms of overactive bladder or any other form of lower urinary tract symptoms

  • Age-matched to case group (+/- 5 years)
  • BMI-matched to case group (18,5- 24,9 kg/m2 normal weight; 25- 29,9 kg/m2 overweight; 30- 34,9 kg/m2 obesity grade I)

Exclusion criteria (control group):

As case group plus any form of lower urinary tract symptoms including OAB

Trial design

100 participants in 2 patient groups

overactive bladder syndrome
Description:
female patients with overactive bladder syndrome
controls
Description:
women without overactive bladder syndrome

Trial contacts and locations

1

Loading...

Central trial contact

Marianne Koch, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems